Physician

Aleya Salam, MD

According to 2025 Medicare claims, Aleya Salam, MD (NPI: 1730128240) practices physical medicine and rehabilitation in the Newark, NJ market, with the plurality of this provider's patient population coming from Hunterdon, NJ. This provider's primary affiliated billing organization is HUNTERDON ORTHOPEDIC INSTITUTE PA (NPI: 1619952595; TIN: 222175464) and primary practice location at 08822-4671.

Salam's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 449 traditional Medicare patients, billed 5,873 HCPCS/CPT codes, and received $194,013 in Medicare payments. The top billing code was 72148 (Mri scan of lower spinal canal without contrast). Part D data shows 1,179 prescription claims across 274 beneficiaries totaling $19,329 in drug costs, led by Buprenorphine (Buprenorphine). DME data shows 40 claims. Open Payments data shows 2 records totaling $43. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $264,411 and ending at $194,013. Concurrently, Part D prescription costs have fallen sharply in recent years, from $167,415 to $19,329. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $0 to $2,074.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	562	3,327	$264,411
2016	608	3,761	$336,767
2017	558	2,944	$239,659
2018	482	2,529	$211,922
2019	499	2,558	$225,463
2020	474	2,614	$228,471
2021	569	3,136	$300,625
2022	525	2,581	$238,723
2023	434	2,148	$200,711
2024	449	5,873	$194,013

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	258	1,350	$167,415
2016	292	1,418	$124,712
2017	282	1,487	$120,866
2018	205	1,119	$88,167
2019	253	1,287	$96,118
2020	282	1,426	$99,523
2021	284	1,194	$77,634
2022	314	1,391	$44,084
2023	265	1,179	$27,219
2024	274	1,179	$19,329

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	24	24	$7,226
2016	29	53	$8,972
2017	18	19	$5,737
2018	13	13	$3,969
2019	21	21	$6,509
2020	14	14	$4,137
2021	13	13	$4,164
2022	18	18	$6,300
2023	14	28	$5,512
2024	12	40	$5,871

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
72148	Mri scan of lower spinal canal without contrast	114	118	$160
64483	Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level	178	240	$124
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	263	451	$104
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	229	379	$74
72100	X-ray of lower and sacral spine, 2-3 views	103	103	$33

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Buprenorphine	Buprenorphine	13	364	$5,859
Celecoxib	Celecoxib	116	3,654	$3,049
Gabapentin	Gabapentin	175	5,867	$1,846
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	132	2,518	$1,381
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	67	1,590	$1,254

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
L0651	Lumbar-sacral orthosis, sagittal-coronal control, rigid shell(s)/panel(s), posterior extends from sacrococcygeal junction to t-9 vertebra, anterior extends from symphysis pubis to xyphoid, produces intracavitary pressure to reduce load on the intervertebral discs, overall strength is provided by overlapping rigid material and stabilizing closures, includes straps, closures, may include soft interface, pendulous abdomen design, prefabricated, off-the-shelf	N	12	12	$3,797
E0745	Neuromuscular stimulator, electronic shock unit	Y	N/R	28	$2,074

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$43	Abbott Laboratories
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Aleya Salam, MD?

Tedicare shows public-source Medicare data for Aleya Salam, MD (NPI 1730128240), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Aleya Salam, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Aleya Salam, MD?

Aleya Salam, MD is linked to HUNTERDON ORTHOPEDIC INSTITUTE PA (billing NPI 1619952595) in the available physician profile data.

Does Aleya Salam, MD have Open Payments data?

Aleya Salam, MD has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.